摘要
采用资料查询,现场实地调研等方式,对江西省吉安地区21家生物制药企业现状进行了调查分析。结果显示吉安地区制药企业数量多,规模整体偏小,发展不稳定,抗风险能力低;企业产品同质化明显,技术含量不高;企业研发能力不强,产品缺少完全自主知识产权;产品销售模式多样,主要以国内市场为主。最后针对其不足提出了相应的对策。
Using information inquiry and on- site investigation methods, a survey study was conducted with 21 bio -pharmaceutical companies in Jiangxi Ji＇an area. The results showed that there are many pharmaceutical companies in Jian area, but the scale is little overall, stability and risk -resisting ability is low, enterprise product homogenization is obvious and technical content is not high, business R ＆ D capability is not strong, the products lack independent intellectual property rights. Products sales model is diversiform, mainly in the domestic market . Finally based on its shortcomings, the corresponding countermeasures were proposed.
出处
《时珍国医国药》
CAS
CSCD
北大核心
2012年第2期478-480,共3页
Lishizhen Medicine and Materia Medica Research
基金
国家自然科学基金(No.30760031)
江西省教改项目(No.JXJG-08-15-32)
